Partner
Angelica Loskog
Scientific adviser, Nxt2b
- Firm
- Nxt2b
- Title
- Scientific adviser
- Role
- Advisor
Claim, correct or request removal
Record updated 20 September 2026
About
Angelica is the CEO of Lokon Pharma AB and a Professor of Immunotherapy at Uppsala University. Angelica is within the field of immune, gene and cell therapy with a focus on cancer and autoimmune disease.
Is this you? Remove my profile
Loading relationship preview